| Bibliographic Citation
| - Largeaud Laetitia, Cornillet-Lefebvre Pascale, Hamel Jean-François, Dumas Pierre-Yves, Prade Naïs, Dufrechou Stéphanie, Plenecassagnes Julien, Luquet Isabelle, Banos Anne, Béné Marie, Bernard Marc, Bertoli Sarah, Bonmati Caroline, Fornecker Luc Matthieu, Guièze Romain, Haddaoui Lamya, Hunault Mathilde, Ianotto Jean Christophe, Jourdan Eric, Vey Norbert, Vey Norbert . Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO study . Leukemia, 2021, 35 (5), pp.1291-1300 . ⟨10.1038/s41375-020-01031-1⟩
- Largeaud Laetitia, Cornillet-Lefebvre Pascale, Hamel Jean-François, Dumas Pierre-Yves, Prade Naïs, Dufrechou Stéphanie, Plenecassagnes Julien, Luquet Isabelle, Blanchet Odile, Banos Anne, Béné Marie, Bernard Marc, Bertoli Sarah, Bonmati Caroline, Fornecker Luc Matthieu, Guièze Romain, Haddaoui Lamya, Hunault Mathilde, Ianotto Jean Christophe, Jourdan Eric, Ojeda Mario, Peterlin Pierre, Vey Norbert, Zerazhi Hacene, Yosr Hicheri, Mineur Ariane, Cahn Jean-Yves, Ifrah Norbert, Récher Christian, Pigneux Arnaud, Delabesse Eric, Marolleau J.-P., Aleme A., Orsini-Piocelle F., Cadoux N., Ifrah Norbert, Hunault Mathilde, Marie C., Al Jijakli A., Lepeu G., Zerazhi Hacene, Beyrne M., Banos Anne, Labarrere S., Deconinck E., Peria M., El Yamani A., Kadiri O., Choufi B., Brument M., Pigneux Arnaud, Leguay T., Dumas Pierre-Yves, Berthou C., Guillerm G., Drugmanne G., Tournilhac O., Roy G., Audhuy B., Camara S., Caillot D., Grandjean M., Cahn Jean-Yves, Bulabois C.-E., Fief B., Vey Norbert, Ladraa C., Dorvaux V., Hagopian M., Fegueux N., Fenoll C., Sabadash V., Ojeda Mario, Haby C., Witz F., Bonmati Caroline, Lhuire M., Delaunay J., Peterlin Pierre, Airiau L., Mannone L., Touitou I., Jourdan Eric, Umuhire D., Alexis M., Michel O., Dreyfus F., Bouscary D., Cheung A., Sanhes L., Touhami F., Ribas E., Puyade M., Gallego-Hernanz M.-P., Hugon N., Himberlin C., Maggi L., Lamy T., Testu A., Tavernier E., Marchand S., Lioure B., Kravanja C., Benboubker L., Nollet D., Attal M., Récher Christian, Sarry A., Lhermitte A., Yrica G., Schwartz D., Le Montagner N., Fenoll C., Sabadash V., Nollet D., Auvray L., Delepine R., Fayault A. . Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO study . Leukemia, 2021, 35 (5), pp.1291-1300 . ⟨10.1038/s41375-020-01031-1⟩
|
![[RDF Data]](/fct/images/sw-rdf-blue.png)
